Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis Reply

被引：0
|
作者：
Toovey, Stephen [1 ]
机构：
[1] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
DRUG SAFETY | 2012年 / 35卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：1188 / 1190
页数：3
相关论文
共 50 条
  • [41] Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study-authors' response
    Kang, Hye-Rim
    Kim, Ju Hwan
    Lee, Eui-Kyung
    Shin, Ju-Young
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (06) : 1764 - 1765
  • [42] Neurologic Adverse Events with the Use of Oseltamivir at Prophylactic vs Therapeutic Dose
    Rodriguez-Silva, Claudia J.
    Martinez, Hector
    Armendariz Betancour, Immer
    Teresa Sanchez, Maria
    Morales, Luis A.
    Estrella Gonzalez-Camid, Maria
    Jacobo Ayala, Juan
    Teresa Luna, Maria
    NEUROLOGY, 2011, 76 (09) : A104 - A104
  • [43] Oseltamivir-induced Neuropsychiatric Symptoms
    Shaik, Arshad Basha
    Prabhu, Mukhyaprana
    Shenoy, Smita
    Thomson, Sereen Rose
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2018, 9 (01) : 43 - 45
  • [44] Adverse neuropsychiatric effects of cytomegalovirus prophylaxis with valaciclovir in renal transplant recipients
    Das, V
    Peraldi, MN
    Legendre, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (05) : 1395 - 1401
  • [45] Statins and Musculoskeletal Adverse Events Reply
    Mansi, Ishak
    Mortensen, Eric M.
    Frei, Christopher R.
    JAMA INTERNAL MEDICINE, 2014, 174 (02) : 303 - 304
  • [46] Adverse events in British hospitals - Reply
    Vincent, C
    Neale, G
    Woloshynowych, M
    BRITISH MEDICAL JOURNAL, 2001, 322 (7299): : 1427 - 1427
  • [47] A review of neuropsychiatric adverse events from topical ophthalmic brimonidine
    Cimolai, N.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2020, 39 (10) : 1279 - 1290
  • [48] Effect of Concomitant Use of Montelukast and Efavirenz on Neuropsychiatric Adverse Events
    Ibarra-Barrueta, Olatz
    Palacios-Zabalza, Itziar
    Mora-Atorrasagasti, Oihana
    Mayo-Suarez, Jose
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (01) : 145 - 148
  • [49] Exenatide and rare adverse events - Reply
    Bloomgren, Gary
    Braun, Daniel
    Kolterman, Orville
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18): : 1971 - 1972
  • [50] Adverse events associated with mefloquine - Reply
    Barrett, P
    BRITISH MEDICAL JOURNAL, 1996, 313 (7071): : 1554 - 1554
12345